QA: Schrodinger Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001490978_2023_Schrodinger_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001490978, Schrodinger Inc.

  xvar xval
0 AssetsCurrent 533,989,000
1 IntangibleAssetsNetIncludingGoodwill 5,378,000
2 PropertyPlantAndEquipmentNet 14,244,000
3 remainder_Assets 134,976,000
4 LiabilitiesCurrent 108,799,000
5 LiabilitiesNoncurrent 131,883,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 79,933,000
8 SellingGeneralAndAdministrativeExpense 90,825,000
9 ResearchAndDevelopmentExpense 126,372,000
10 remainder_Expenses 30,705,000
11 remainder_Revenues 180,955,000
12 remainder_NetIncome -2,309,000
13 remainder_ComprehensiveNetIncome -1,728,000
  yvar yval
0 Assets 688,587,000
1 Liabilities 240,682,000
2 Expenses 327,835,000
3 Revenues 180,955,000
4 StockholdersEquity 447,905,000
5 NetIncome -149,189,000
6 ComprehensiveNetIncome -150,053,000
7 BaseVar 721,048,000
8 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time